Stockreport

Orano Announces Leadership Transition in Orano Med [Yahoo! Finance]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF of its subsidiary Orano Med, a pioneer in the development of targeted alphatherapies in oncology. After a successful eight-year tenure as CEO, Julien DODET will transiti [Read more]